Drug Trial Radar · NCT05054114
Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
Last checked: Nov 20, 2026Latest source record: Aug 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
630
Actual
Start
Dec 21, 2020
Primary completion
May 25, 2021
Study completion Sep 2, 2021
Sponsor
- Lead sponsor
- SPP Pharmaclon Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 23, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
It is known that the pretreatment with exogenous interferon blocks SARS-CoV-2 infection, but intervention is much more effective if administered prior to infection. In this study the primary aim is to investigate 28-day regime of nasal interferon gama use in healthy participants for COVID-19 and other respiratory infections prevention.
Conditions
- COVID-19 Respiratory Infection
- Acute Respiratory Disease
Interventions
Interferon gamma human recombinant (IFN-G)Drug
nasal form
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Proportion of Patients With Acute Respiratory Viral Infections, Including COVID-19, at the End of the Prophylactic PeriodTime frame: 28 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
City Clinical Hospital named after M.E. Zhadkevich Moscow City Health Department
Moscow, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.